Covid-19 Small Molecule Drugs Market, Global Outlook and Forecast 2022-2028

April 2022 | 60 pages | ID: C14FB6689C39EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Covid-19 Small Molecule Drugs in Global, including the following market information:

Global Covid-19 Small Molecule Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Covid-19 Small Molecule Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

RdRp Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Covid-19 Small Molecule Drugs include Shanghai Junshi biosciences, Ascletis Pharma, Merck and Co (MSD), Pfizer and Shionogi, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Covid-19 Small Molecule Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Covid-19 Small Molecule Drugs Market, by Targets, 2017-2022, 2023-2028 ($ millions)

Global Covid-19 Small Molecule Drugs Market Segment Percentages, by Targets, 2021 (%)

• RdRp
• 3CLpro

Global Covid-19 Small Molecule Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Covid-19 Small Molecule Drugs Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Scientific Research

Global Covid-19 Small Molecule Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Covid-19 Small Molecule Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Covid-19 Small Molecule Drugs revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Covid-19 Small Molecule Drugs revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Shanghai Junshi biosciences
• Ascletis Pharma
• Merck and Co (MSD)
• Pfizer
• Shionogi

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Covid-19 Small Molecule Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Targets
  1.2.2 Market by Application
1.3 Global Covid-19 Small Molecule Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL COVID-19 SMALL MOLECULE DRUGS OVERALL MARKET SIZE

2.1 Global Covid-19 Small Molecule Drugs Market Size: 2021 VS 2028
2.2 Global Covid-19 Small Molecule Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Covid-19 Small Molecule Drugs Players in Global Market
3.2 Top Global Covid-19 Small Molecule Drugs Companies Ranked by Revenue
3.3 Global Covid-19 Small Molecule Drugs Revenue by Companies
3.4 Top 3 and Top 5 Covid-19 Small Molecule Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Covid-19 Small Molecule Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Covid-19 Small Molecule Drugs Players in Global Market
  3.6.1 List of Global Tier 1 Covid-19 Small Molecule Drugs Companies
  3.6.2 List of Global Tier 2 and Tier 3 Covid-19 Small Molecule Drugs Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Targets - Global Covid-19 Small Molecule Drugs Market Size Markets, 2021 & 2028
  4.1.2 RdRp
  4.1.3 3CLpro
4.2 By Targets - Global Covid-19 Small Molecule Drugs Revenue & Forecasts
  4.2.1 By Targets - Global Covid-19 Small Molecule Drugs Revenue, 2017-2022
  4.2.2 By Targets - Global Covid-19 Small Molecule Drugs Revenue, 2023-2028
  4.2.3 By Targets - Global Covid-19 Small Molecule Drugs Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Covid-19 Small Molecule Drugs Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Scientific Research
5.2 By Application - Global Covid-19 Small Molecule Drugs Revenue & Forecasts
  5.2.1 By Application - Global Covid-19 Small Molecule Drugs Revenue, 2017-2022
  5.2.2 By Application - Global Covid-19 Small Molecule Drugs Revenue, 2023-2028
  5.2.3 By Application - Global Covid-19 Small Molecule Drugs Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Covid-19 Small Molecule Drugs Market Size, 2021 & 2028
6.2 By Region - Global Covid-19 Small Molecule Drugs Revenue & Forecasts
  6.2.1 By Region - Global Covid-19 Small Molecule Drugs Revenue, 2017-2022
  6.2.2 By Region - Global Covid-19 Small Molecule Drugs Revenue, 2023-2028
  6.2.3 By Region - Global Covid-19 Small Molecule Drugs Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Covid-19 Small Molecule Drugs Revenue, 2017-2028
  6.3.2 US Covid-19 Small Molecule Drugs Market Size, 2017-2028
  6.3.3 Canada Covid-19 Small Molecule Drugs Market Size, 2017-2028
  6.3.4 Mexico Covid-19 Small Molecule Drugs Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Covid-19 Small Molecule Drugs Revenue, 2017-2028
  6.4.2 Germany Covid-19 Small Molecule Drugs Market Size, 2017-2028
  6.4.3 France Covid-19 Small Molecule Drugs Market Size, 2017-2028
  6.4.4 U.K. Covid-19 Small Molecule Drugs Market Size, 2017-2028
  6.4.5 Italy Covid-19 Small Molecule Drugs Market Size, 2017-2028
  6.4.6 Russia Covid-19 Small Molecule Drugs Market Size, 2017-2028
  6.4.7 Nordic Countries Covid-19 Small Molecule Drugs Market Size, 2017-2028
  6.4.8 Benelux Covid-19 Small Molecule Drugs Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Covid-19 Small Molecule Drugs Revenue, 2017-2028
  6.5.2 China Covid-19 Small Molecule Drugs Market Size, 2017-2028
  6.5.3 Japan Covid-19 Small Molecule Drugs Market Size, 2017-2028
  6.5.4 South Korea Covid-19 Small Molecule Drugs Market Size, 2017-2028
  6.5.5 Southeast Asia Covid-19 Small Molecule Drugs Market Size, 2017-2028
  6.5.6 India Covid-19 Small Molecule Drugs Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Covid-19 Small Molecule Drugs Revenue, 2017-2028
  6.6.2 Brazil Covid-19 Small Molecule Drugs Market Size, 2017-2028
  6.6.3 Argentina Covid-19 Small Molecule Drugs Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Covid-19 Small Molecule Drugs Revenue, 2017-2028
  6.7.2 Turkey Covid-19 Small Molecule Drugs Market Size, 2017-2028
  6.7.3 Israel Covid-19 Small Molecule Drugs Market Size, 2017-2028
  6.7.4 Saudi Arabia Covid-19 Small Molecule Drugs Market Size, 2017-2028
  6.7.5 UAE Covid-19 Small Molecule Drugs Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Shanghai Junshi biosciences
  7.1.1 Shanghai Junshi biosciences Corporate Summary
  7.1.2 Shanghai Junshi biosciences Business Overview
  7.1.3 Shanghai Junshi biosciences Covid-19 Small Molecule Drugs Major Product Offerings
  7.1.4 Shanghai Junshi biosciences Covid-19 Small Molecule Drugs Revenue in Global Market (2017-2022)
  7.1.5 Shanghai Junshi biosciences Key News
7.2 Ascletis Pharma
  7.2.1 Ascletis Pharma Corporate Summary
  7.2.2 Ascletis Pharma Business Overview
  7.2.3 Ascletis Pharma Covid-19 Small Molecule Drugs Major Product Offerings
  7.2.4 Ascletis Pharma Covid-19 Small Molecule Drugs Revenue in Global Market (2017-2022)
  7.2.5 Ascletis Pharma Key News
7.3 Merck and Co (MSD)
  7.3.1 Merck and Co (MSD) Corporate Summary
  7.3.2 Merck and Co (MSD) Business Overview
  7.3.3 Merck and Co (MSD) Covid-19 Small Molecule Drugs Major Product Offerings
  7.3.4 Merck and Co (MSD) Covid-19 Small Molecule Drugs Revenue in Global Market (2017-2022)
  7.3.5 Merck and Co (MSD) Key News
7.4 Pfizer
  7.4.1 Pfizer Corporate Summary
  7.4.2 Pfizer Business Overview
  7.4.3 Pfizer Covid-19 Small Molecule Drugs Major Product Offerings
  7.4.4 Pfizer Covid-19 Small Molecule Drugs Revenue in Global Market (2017-2022)
  7.4.5 Pfizer Key News
7.5 Shionogi
  7.5.1 Shionogi Corporate Summary
  7.5.2 Shionogi Business Overview
  7.5.3 Shionogi Covid-19 Small Molecule Drugs Major Product Offerings
  7.5.4 Shionogi Covid-19 Small Molecule Drugs Revenue in Global Market (2017-2022)
  7.5.5 Shionogi Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Covid-19 Small Molecule Drugs Market Opportunities & Trends in Global Market
Table 2. Covid-19 Small Molecule Drugs Market Drivers in Global Market
Table 3. Covid-19 Small Molecule Drugs Market Restraints in Global Market
Table 4. Key Players of Covid-19 Small Molecule Drugs in Global Market
Table 5. Top Covid-19 Small Molecule Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Covid-19 Small Molecule Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Covid-19 Small Molecule Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Covid-19 Small Molecule Drugs Product Type
Table 9. List of Global Tier 1 Covid-19 Small Molecule Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Covid-19 Small Molecule Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Targets – Global Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Targets - Covid-19 Small Molecule Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Targets - Covid-19 Small Molecule Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Covid-19 Small Molecule Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Covid-19 Small Molecule Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Covid-19 Small Molecule Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Covid-19 Small Molecule Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2023-2028
Table 30. Shanghai Junshi biosciences Corporate Summary
Table 31. Shanghai Junshi biosciences Covid-19 Small Molecule Drugs Product Offerings
Table 32. Shanghai Junshi biosciences Covid-19 Small Molecule Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Ascletis Pharma Corporate Summary
Table 34. Ascletis Pharma Covid-19 Small Molecule Drugs Product Offerings
Table 35. Ascletis Pharma Covid-19 Small Molecule Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Merck and Co (MSD) Corporate Summary
Table 37. Merck and Co (MSD) Covid-19 Small Molecule Drugs Product Offerings
Table 38. Merck and Co (MSD) Covid-19 Small Molecule Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Pfizer Corporate Summary
Table 40. Pfizer Covid-19 Small Molecule Drugs Product Offerings
Table 41. Pfizer Covid-19 Small Molecule Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Shionogi Corporate Summary
Table 43. Shionogi Covid-19 Small Molecule Drugs Product Offerings
Table 44. Shionogi Covid-19 Small Molecule Drugs Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Covid-19 Small Molecule Drugs Segment by Targets in 2021
Figure 2. Covid-19 Small Molecule Drugs Segment by Application in 2021
Figure 3. Global Covid-19 Small Molecule Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Covid-19 Small Molecule Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Covid-19 Small Molecule Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Covid-19 Small Molecule Drugs Revenue in 2021
Figure 8. By Targets - Global Covid-19 Small Molecule Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Covid-19 Small Molecule Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Covid-19 Small Molecule Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Covid-19 Small Molecule Drugs Revenue Market Share, 2017-2028
Figure 12. US Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Covid-19 Small Molecule Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Covid-19 Small Molecule Drugs Revenue Market Share, 2017-2028
Figure 24. China Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Covid-19 Small Molecule Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Covid-19 Small Molecule Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Covid-19 Small Molecule Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. Shanghai Junshi biosciences Covid-19 Small Molecule Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Ascletis Pharma Covid-19 Small Molecule Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Merck and Co (MSD) Covid-19 Small Molecule Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Pfizer Covid-19 Small Molecule Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Shionogi Covid-19 Small Molecule Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)